Krsnaa Diagnostics Limited has informed the Exchange regarding 'Submission of revised Investor Presentation for quarter and half year ended September 30, 2025'.
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krsnaa Diagnostics has submitted a revised investor presentation to the stock exchanges covering its results for the quarter and half year ended September 30, 2025 (Q2 FY26 and H1 FY26). The filing is a revised version, suggesting some updates or corrections were made to the original presentation shared earlier. The actual financial details, guidance, and business outlook would be contained within the presentation document itself. Shareholders and analysts typically look at such presentations for management commentary on performance, strategy, and growth plans.
This is a routine corporate disclosure and does not, on its own, signal any positive or negative change for shareholders. Investors should review the presentation contents for any updated guidance, new strategic initiatives, or changes in business outlook.